Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Iridex Q3 EPS $(0.11) Beats $(0.12) Estimate, Sales $12.85M Miss $13.48M Estimate

Author: Benzinga Newsdesk | November 14, 2023 06:21pm
Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 8.33 percent. This is unchanged from the same period last year. The company reported quarterly sales of $12.85 million which missed the analyst consensus estimate of $13.48 million by 4.67 percent. This is a 12.20 percent decrease over sales of $14.63 million the same period last year.

Posted In: IRIX